Mark Frye, MD

Dr. Mark A. Frye is a distinguished psychiatrist with a strong research focus on genomics, brain imaging, and neuroendocrinology, specifically concerning mood disorders and alcoholism. His clinical interests lie in the areas of bipolar disorder, depression, and alcoholism.

Dr. Frye’s groundbreaking research has garnered support from esteemed institutions and organizations. He receives research funding from the National Institute of Mental Health, as well as the Mayo Clinic’s Samuel C. Johnson Genomics of Addiction Program, SC Johnson Giving, Inc., the Marriott family, and the Mayo Clinic Center for Individualized Medicine. Furthermore, he has also received funding from the National Institute on Alcohol Abuse and Alcoholism.

Through his research endeavors, Dr. Frye aims to advance our understanding of the underlying mechanisms and genetic factors contributing to mood disorders and alcoholism. His work combines cutting-edge techniques such as genomics and brain imaging, along with an exploration of the complex interplay between neuroendocrinology and these conditions.
Dr. Mark A. Frye’s dedication to research and clinical practice in the field of psychiatry has positioned him as a leading expert. His research support from prestigious institutions and funding agencies underscores the significance of his work and its potential to impact the lives of individuals affected by mood disorders and alcoholism.